# clm_A2ED4BA1F89D

subject: AbbVie (/record/abbvie.md)  
predicate: cash_and_equivalents  
value: 9,746,000,000 United States dollar  
valid_from: 2021-12-31  
valid_to: 2022-03-31  
published: 2022-02-18  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C8B5152DE66D  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie cash and equivalents: 9,746,000,000 United States dollar", as of 2021-12-31 (until 2022-03-31). Claim clm_A2ED4BA1F89D, https://asof.is/claim/clm_A2ED4BA1F89D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-18  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm (primary, SEC EDGAR 10-K FY2021, published 2022-02-18)

## Supersedes

- [AbbVie](/record/abbvie.md) | cash_and_equivalents | 12,182,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_A2ED4BA1F89D](/claim/clm_A2ED4BA1F89D.md) | [clm_90B6D4FB71C7](/claim/clm_90B6D4FB71C7.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.